PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Allergy & Clinical Immunology, Department of Medicine, University of Virginia, Charlottesville, VA, United States.\', \'Division of Infectious Disease and International Medicine, Department of Medicine, University of Virginia, Charlottesville, VA, United States.\', \'Division of Pulmonary and Critical Care, Department of Medicine, University of Virginia, Charlottesville, VA, United States.\', \'Department of Pharmacology, University of Virginia, Charlottesville, VA, United States.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3389/fimmu.2022.850987
?:doi
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 35386716
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
?:title
  • Trajectory of IgG to SARS-CoV-2 After Vaccination With BNT162b2 or mRNA-1273 in an Employee Cohort and Comparison With Natural Infection.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35386716>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35386716>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all